You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Attention Score in Context
Cost of illness and economic evaluation in rare diseases
Rare Diseases Epidemiology
Advances in experimental medicine and biology, August 2010
López-Bastida J, Oliva-Moreno J, Julio López-Bastida, Juan Oliva-Moreno PhD, Juan Oliva-Moreno
Manuel Posada de la Paz, Stephen C. Groft
The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||3||60%|
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||19||32%|
|Student > Master||7||12%|
|Student > Doctoral Student||4||7%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||16||27%|
|Pharmacology, Toxicology and Pharmaceutical Science||4||7%|
|Economics, Econometrics and Finance||4||7%|
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2017.
All research outputs
of 22,852,911 outputs
Outputs from Advances in experimental medicine and biology
of 4,950 outputs
Outputs of similar age
of 95,042 outputs
Outputs of similar age from Advances in experimental medicine and biology
of 11 outputs
Altmetric has tracked 22,852,911 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 4,950 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,042 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.